Your browser doesn't support javascript.
loading
Effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules.
Wang, Qingfeng; Liu, Hongyan; Xu, Zhibiao; Zhang, Li; Liu, Yuyun; Gao, Han; Jiang, Yunru; Zhao, Linlin.
Afiliação
  • Wang Q; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China; Department of Anesthesiology, the Second Affiliated Hospital of Nantong University, Nantong City 226000, China; Department of Anesthesiology, the First People's Hospital of Nantong, Nantong City 226000, China.
  • Liu H; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Xu Z; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Zhang L; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Liu Y; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Gao H; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Jiang Y; School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
  • Zhao L; Department of Anesthesiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou City 221002, China; Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China. Electronic address: lin1675@163.com.
Lung Cancer ; 194: 107888, 2024 Jul 09.
Article em En | MEDLINE | ID: mdl-39043077
ABSTRACT

OBJECTIVE:

To investigate the effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules. MATERIALS AND

METHODS:

In this randomized, placebo-controlled and single-center study, 120 patients were allocated randomly to four groups the control group (Group P), the pregabalin-placebo group (Group BP), the tramadol/paracetamol-placebo group (Group AP), and the pregabalin-tramadol/paracetamol group (Group AB). The primary outcome was the NRS (Numerical Rating Scale) score. Other outcomes included systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), pulse oxygen saturation (SpO2), the incidence of moderate to severe pain, the analgesia recovery ratio, the incidence of adverse drug reactions and patients' satisfaction.

RESULTS:

No significant interaction was detected between the interventions (P = 0.752). The NRS score of the Taking pregabalin group and the Taking tramadol/paracetamol group were significantly lower than those of the Not-taking pregabalin group and the Not-taking tramadol/paracetamol group respectively (P < 0.05). There was significant difference in the NRS scores among the four groups (P < 0.001). The NRS score of Group AB was significantly lower than that of Group P (P < 0.001), Group BP (P < 0.001) and Group AP (P = 0.001). At the same time, the NRS scores of Group BP (P < 0.001) and Group AP (P < 0.001) were significantly lower than those of Group P, but there was no significant difference between Group BP and Group AP (P = 1.000). The SBP, DBP, HR, the incidence of moderate to severe pain and the analgesia recovery ratio of Group AB were significantly lower than those of Group P (P < 0.05), while the SpO2 and the number of people who were very satisfied were significantly higher than those of Group P (P < 0.05). There was no significant difference in the incidence of adverse drug reactions among the four groups (P = 0.272).

CONCLUSIONS:

The combination or single use of pregabalin and tramadol/paracetamol can effectively relieve the acute pain after localization. Pregabalin combined with tramadol/paracetamol has the best analgesic effect and significantly reduces the hemodynamic fluctuations, with high safety and low incidence of adverse drug reactions, which has a certain clinical popularization and application value.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China